Sage Therapeutics, Inc. ( SAGE) - Stock Earnings
Stock symbol SAGE is outdated, potentially delisted? Maybe it is available on other exchange?
SAGE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -95.8 million USD | 12.8 million USD |
| 2025Q1 | -62.2 million USD | 14.1 million USD |
| 2025Q2 | -49.7 million USD | 31.7 million USD |
SAGE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -503.3 million USD | 7.7 million USD |
| 2023 | -541.5 million USD | 86.5 million USD |
| 2024 | -400.7 million USD | 41.2 million USD |
SAGE
Price: $8.68
52 week price:
Earnings Per Share: -4.89 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 427700
Ebitda: -74.2 millionMarket Capitalization: 544.9 million